NIRV Share Price Performance
Recent NIRV News & Updates
No updates
Nirvana Life Sciences Inc. Key Details
Last Reported Earnings
Jan 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.11
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -7.3%
Nirvana Life Sciences Inc. Competitors
About NIRV
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Nirvana Life Sciences Inc. engages in the research and development of therapeutic products to address addiction. The company is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: -1.8%
- 3 Months: 7.8%
- 1 Year: 18.5%
- Year to Date: 8.6%
Over the last 7 days, the market has dropped 1.8%, driven by pullbacks in every sector, especially the Financials sector. As for the longer term, the market has actually risen by 19% in the last year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading